Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared on LinkedIn:
“Very informative poster presentation by Jan Witowski at the 2024 San Antonio Breast Cancer Symposium.
The clinical validation results of Ataraxis Breast–the first AI-native prognostic/predictive test for breast cancer patients are impressive.
Looking forward to continuing our collaboration with Ataraxis AI on the validation and implementation of AI prognostic and predictive models at Northwell Cancer Institute.”